Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05883436 · ClinicalTrials.gov registry record · NA
Investigation of DEXA-C Anterior Cervical Interbody System
A NA study of Degenerative Disc Disease, sponsored by Aurora Spine and Pain.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 4
- Study locations
NCT05883436: Recruiting NA study of Degenerative Disc Disease, sponsored by Aurora Spine and Pain.
NCT05883436 is a NA study of Degenerative Disc Disease that is actively recruiting participants, run by Aurora Spine and Pain. The registered enrollment target is 80 participants, below the 167-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (52% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05883436, a NA study of Degenerative Disc Disease, is actively recruiting participants, sponsored by Aurora Spine and Pain.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 4
- Study locations
Study Summary
FDA Cleared interbody product for the cervical spine, designed to match a patients DEXA scan for increase in fusion rate.
Primary Outcome
The primary outcomes of interest for this study will be fusion assessment at 3 months, 6 months and 12 months post-surgery. Fusion assessment from Static and Dynamic X-Ray (AP/LAT/Flex/Ex) using the following criteria: Bridging bone inside or outside of graft No lucencies at the graft-vertebral body junction Motion \< 1mm
Conditions Studied
Interventions
- DEVICE DEXA-C Cervical Interbody System
Study Locations (4)
California
- UCI Center for Clinical Research - Orange
Kentucky
- Orthopaedic Institute of Western KY - Paducah
Louisiana
- Koga Neurosurgery - Covington
Oklahoma
- Optima Orthopedics - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-02-22 |
| Est. Completion | 2027-02-22 |
| Phase | NA |
What NCT05883436 shows while recruiting
NCT05883436 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 167-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which DEXA-C Cervical Interbody System is the first listed.
NCT05883436 reports a single indexed study location in California, Kentucky, Louisiana.
Frequently Asked Questions
What is clinical trial NCT05883436 about?
NCT05883436 is a clinical study titled "Investigation of DEXA-C Anterior Cervical Interbody System". FDA Cleared interbody product for the cervical spine, designed to match a patients DEXA scan for increase in fusion rate.
What is the current status of trial NCT05883436?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-02-22. Estimated completion is 2027-02-22.
What conditions does trial NCT05883436 study?
This clinical trial studies the following conditions: Degenerative Disc Disease.
What interventions are being tested in trial NCT05883436?
The interventions under investigation include: DEXA-C Cervical Interbody System (DEVICE).
Who is sponsoring clinical trial NCT05883436?
This trial is sponsored by Aurora Spine and Pain, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05883436 being conducted?
This trial has 4 study locations across California, Kentucky, Louisiana, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05883436's enrollment target sits among peer trials
80 24th of 42 higher than 19 of 42 other Degenerative Disc Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Degenerative Disc Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
RECRUITING · NA
-
Trial for Treating Painful Degenerative Disc Disease
RECRUITING · NA
-
Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.
RECRUITING · NA
-
MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion
RECRUITING · NA
-
ACDF Using Structural Allograft vs. Tritanium C
RECRUITING · NA
-
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI